Ironwood Investment Management LLC Denali Therapeutics Inc. Transaction History

Ironwood Investment Management LLC

$198 Million
Q1 2024

A detailed history of Ironwood Investment Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Ironwood Investment Management LLC holds 36,064 shares of DNLI stock, worth $784,031. This represents 0.37% of its overall portfolio holdings.

Number of Shares

36,064

Previous 17,938 101.05%

Holding current value

$784,031

Previous $384,000 92.71%

% of portfolio

0.37%

Previous 0.21%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $286,934 - $423,242	18,126 Added 101.05%	36,064 $740,000
Q4 2023 Feb 14, 2024	SELL	$16.2 - $23.18 $2,559 - $3,662	-158 Reduced 0.87%	17,938 $384,000
Q3 2023 Nov 16, 2023	SELL	$20.63 - $30.17 $12,852 - $18,795	-623 Reduced 3.33%	18,096 $373,000
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $437,463 - $616,978	18,719 New	18,719 $552,000
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $7,734 - $11,532	-353 Reduced 1.84%	18,796 $433,000

Q4 2022 Jan 31, 2023	SELL	$26.28 - $33.92 $19,946 - $25,745	-759 Reduced 3.81%	19,149 $532,000
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $1,350 - $2,003	52 Added 0.26%	19,908 $611,000
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $292 - $492	14 Added 0.07%	19,856 $584,000
Q1 2022 May 10, 2022	BUY	$29.0 - $47.27 $13,311 - $21,696	459 Added 2.37%	19,842 $638,000
Q4 2021 Feb 10, 2022	BUY	$42.59 - $55.02 $12,351 - $15,955	290 Added 1.52%	19,383 $864,000
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $921 - $1,486	19 Added 0.1%	19,093 $963,000
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $22,433 - $34,984	-446 Reduced 2.28%	19,074 $1.5 Million
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $8,339 - $12,637	155 Added 0.8%	19,520 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $20,400 - $51,738	-553 Reduced 2.78%	19,365 $1.62 Million
Q3 2020 Nov 13, 2020	SELL	$23.13 - $38.84 $925 - $1,553	-40 Reduced 0.2%	19,918 $714,000
Q2 2020 Aug 17, 2020	SELL	$16.01 - $28.82 $1,793 - $3,227	-112 Reduced 0.56%	19,958 $483,000
Q1 2020 May 14, 2020	SELL	$14.2 - $27.98 $10,522 - $20,733	-741 Reduced 3.56%	20,070 $351,000
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $24,422 - $33,903	-1,696 Reduced 7.54%	20,811 $363,000
Q3 2019 Nov 13, 2019	SELL	$15.32 - $21.92 $1,348 - $1,928	-88 Reduced 0.39%	22,507 $345,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $28.14 $222 - $337	-12 Reduced 0.05%	22,595 $469,000
Q1 2019 May 08, 2019	BUY	$17.99 - $24.65 $225,144 - $308,494	12,515 Added 124.01%	22,607 $525,000
Q4 2018 Feb 12, 2019	BUY	$13.88 - $21.75 $140,076 - $219,501	10,092 New	10,092 $209,000

Others Institutions Holding DNLI

# of Institutions

217

Shares Held

115M

Call Options Held

142K

Put Options Held

90.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.92B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.

Account

Ironwood Investment Management LLC Denali Therapeutics Inc. Transaction History